Rejoinder: Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes

Biometrics. 2021 Dec;77(4):1492-1494. doi: 10.1111/biom.13495. Epub 2021 May 29.
No abstract available

MeSH terms

  • COVID-19 Drug Treatment*
  • Data Interpretation, Statistical
  • Humans
  • Randomized Controlled Trials as Topic
  • SARS-CoV-2